Page last updated: 2024-09-05

ly 300164 and 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione

ly 300164 has been researched along with 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione in 1 studies

Compound Research Comparison

Studies
(ly 300164)
Trials
(ly 300164)
Recent Studies (post-2010)
(ly 300164)
Studies
(6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione)
Trials
(6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione)
Recent Studies (post-2010) (6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione)
737123612

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inami, H; Kato, K; Ohno, K; Sakamoto, S; Shishikura, J; Yamashita, H; Yasunaga, T1

Other Studies

1 other study(ies) available for ly 300164 and 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione

ArticleYear
Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
    Bioorganic & medicinal chemistry, 2015, Apr-15, Volume: 23, Issue:8

    Topics: Animals; Anticonvulsants; Antinematodal Agents; Cells, Cultured; Electroshock; Hippocampus; Kainic Acid; Mice; Neurons; Pyridines; Rats; Receptors, AMPA; Seizures; Structure-Activity Relationship; Thiazines

2015